Zentiva to apply for termination of its listing on the Prague Stock Exchange

Following is the full version of Zentiva press release:

Prague, London, March 24, 2009 – Today, Zentiva N.V. (the “Company” or “Zentiva”) applied to the Prague Stock Exchange for termination of the listing of its shares on the Prague Stock Exchange. The application for delisting was made in accordance with Section 60 of Czech Act No. 256/2004 Coll., as amended, and in accordance with Article 10 of the Prague Stock Exchange Listing Rules. Zentiva intends that the delisting will become effective on April 28, 2009 (i.e., the last trading date will be April 27, 2009).

Zentiva notes that under Dutch corporate law, the only pre-requisite for delisting of its shares from the Prague Stock Exchange was a decision of Zentiva’s Board, which was already taken on March 11, 2009. Zentiva also notes the intention of its majority shareholder, Sanofi-Aventis Europe, to proceed with the squeeze-out procedure under applicable Dutch law. Zentiva expects that Sanofi-Aventis Europe will initiate the relevant Dutch court proceedings in May 2009 and will propose in such court proceedings that the squeeze-out price be identical to the improved offer price of CZK 1,150. The final squeeze-out price will be subject to the court’s approval.

In a separate announcement today, Zentiva announced its application for delisting of its global depositary shares from the London Stock Exchange, with the intention that such delisting becomes effective on April 24, 2009 (i.e., the last trading date will be April 23, 2009). In this regard, today Zentiva also filed a notice with The Bank of New York Mellon Corporation for termination of the deposit agreements with respect to Zentiva’s global depositary shares. Pursuant to this notice, the global depositary shares facilities will be terminated as of June 30, 2009.